Articles published in Brain Disorders & Therapy have been cited by esteemed scholars and scientists all around the world. Brain Disorders & Therapy has got h-index 12, which means every article in Brain Disorders & Therapy has got 12 average citations.

Following are the list of articles that have cited the articles published in Brain Disorders & Therapy.

  2021 2020 2019 2018 2017

Year wise published articles

46 13 13 11 16

Year wise citations received

103 84 90 74 83
Journal total citations count 713
Journal h-index 12
Important citations

Perera N, Javeed M, Lyketsos CG, Leroi I. Neuropsychiatric aspects of dementia. InDementia 2017:79-86.

Khadijah B. Research & Reviews: Journal of Medical and Health Sciences.  

Kiran Mayee K. Emerging Trends in Neuropsychiatry.

Zasler ND, Aloisi M, Contrada M, Formisano R. Disorders of consciousness terminology: history, evolution and future directions. Brain injury. 20;9:1-6.

赵文波. 脊髓损伤后脑脊液在内源性神经干细胞增殖分化中作用的实验研究进展. 贵州医药. 2016 Nov 11(2016 年 09):992-4.

Danielski LG. Avaliação da neuroproteção da vitamina B6 na sepse experimental. Programa de Pós-Graduação em Ciência da Saúde. 2016.

Грабчак ОІ. Метаболізм рибофлавіну до його коферментних форм в тканинах щурів різного віку.

Huang H. Mass Spectrometry-Based Metabolomics: Platform Development and Application to Neurodegenerative Disease (Doctoral dissertation, University of Akron).

牛曼曼, 韩颖, 秦炯, 杜军保, 金红芳, 赵阳, 张静, 李沁芮. FMR1 基因前突变的临床表现和分子机制. 中华实用儿科临床杂志. 2016 Jan 11(2016 年 20):1588-90.

Salcedo-Arellano MJ, Hagerman RJ, Martínez-Cerdeño V. Síndrome de temblor y ataxia asociado al X frágil: presentación clínica, patología y tratamiento. revista de Neurología. 2019;199.

Srilatha B. A Review on Genetic Disorders and Syndromes. Biochem Mol Biol Lett. 2017;3(2):118.

El-Deeb M, Adams P, Schneider A, Salcedo-Arellano MJ, Tassone F, Hagerman R. Research Open. Journal of Molecular Genetics. 2018;1:1-4.

G Tan MM, S Dy JB, Salcedo-Arellano MJ, Tassone F, Hagerman RJ. Fragile X-associated neuropsychiatric disorders: a case report. Future Neurology. 2019:14.

Bonapace G, Gullace R, Concolino D, Iannello G, Procopio R, Gagliardi M, et al. Intracellular FMRpolyG-Hsp70 complex in fibroblast cells from a patient affected by fragile X tremor ataxia syndrome. Heliyon. 2019;5.

Akash R, Jasdeep S, Salcedo-Arellano M, Wilmar S, Xianlai D, Hagerman R. Fragile X syndrome and fragile X-associated disorders. F1000Research. 2017;6.

Wheeler AC, Miller S, Wylie A, Edwards A. Mindfulness and Acceptance as Potential Protective Factors for Mothers of Children With Fragile X Syndrome. Frontiers in public health. 2018;6:316.

Famula JL, McKenzie F, McLennan YA, Grigsby J, Tassone F, Hessl D, Rivera SM, Martinez-Cerdeno V, Hagerman RJ. Presence of middle cerebellar peduncle sign in FMR1 premutation carriers without tremor and ataxia. Frontiers in neurology. 2018;9.

El-Deeb M, Adams P, Schneider A, Salcedo-Arellano MJ, Tassone F, Hagerman R. Fentanyl Overdose in a female with the FMR1 premutation and FXTAS. Journal of molecular genetics (Isleworth, London, England). 2018;1.

Ligsay A, El-Deeb M, Salcedo-Arellano MJ, Schloemerkemper N, Grayson JS, Hagerman R. General anesthetic use in fragile X Spectrum disorders. Journal of neurosurgical anesthesiology. 2019;31:285-90.

Ligsay A, El-Deeb M, Salcedo-Arellano MJ, Schloemerkemper N, Grayson JS, Hagerman R. General anesthetic use in fragile X Spectrum disorders. Journal of neurosurgical anesthesiology. 2019;31:285-90.